Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Apoquel
2. Oclacitinib
1. 1208319-27-0
2. Oclacitinib (maleate)
3. 1640292-55-2
4. Apoquel
5. Oclacitinib Maleate [usan]
6. Oclacitinib Maleate(pf-03394197)
7. Pf-03394197-11
8. Von733l42a
9. Oclacitinib Maleate (usan)
10. (z)-but-2-enedioic Acid;n-methyl-1-[4-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
11. N-methyl(trans-4-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclohexyl) Methanesulfonamide (2z)-2-butenedioate
12. Unii-von733l42a
13. Oclacitinib(maleate)
14. Pf-03394197 Maleate
15. Schembl260868
16. Chembl2105739
17. Oclacitinib Maleate [mi]
18. Schembl19205843
19. Amy19492
20. Ex-a3658
21. Hy-13577a
22. S8195
23. Ccg-269269
24. Cs-7611
25. Ac-32980
26. Bs-44681
27. D10142
28. D84061
29. Oclacitinib Maleate (ema Epar: Veterinary)
30. Pf 03394197-11
31. Q27291934
32. Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4- Ylamino)-, Trans-, (2z)-2-butenedioate (1:?)
33. N-methyl-1-((1r,4r)-4-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide Maleate
34. N-methyl-1-(trans-4-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide Maleate(1:x)
| Molecular Weight | 453.5 g/mol |
|---|---|
| Molecular Formula | C19H27N5O6S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 453.16820477 g/mol |
| Monoisotopic Mass | 453.16820477 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 606 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
- Treatment of pruritus associated with allergic dermatitis in dogs.
- Treatment of clinical manifestations of atopic dermatitis in dogs.
QD11AH90
NDC Package Code : 17205-097
Start Marketing Date : 2019-04-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 54771-1344
Start Marketing Date : 2020-03-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF Number : 6276
Submission : 2018-10-25
Status : Active
Type : II

VMF Number : 6311
Submission : 2019-06-20
Status : Active
Type : II

VMF Number : 6310
Submission : 2019-06-20
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Sichuan Qingmu Pharmaceutical Co., Ltd. is an innovation-driven pharmaceutical company focused on regulated markets. We specialize in the R&D and manufacturing of generic APIs and ...
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
About the Company : Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists ...
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
About the Company : Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates, CDMO/CRO/OEM, and Technology Transfer of Finished Formulat...
Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.
About the Company : Cosma S.p.A., part of the CFM Group along with AMSA and Clarochem Ireland, is the group’s largest manufacturing site, located in Bergamo, Italy. With a 130,000L glass-lined react...
About the Company : Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API...

About the Company : Almelo are the industry leaders in manufacturing advanced intermediates, Active Pharmaceutical Ingredients (APIs) and specialty fine chemicals. With a diverse product portfolio cou...

About the Company : NGL Fine-Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. We cater to various global companies to custom manufacture high q...

About the Company : The Quality Assurance department is the Guardian of Quality within the Company. We have a team dedicated to identifying and implementing new ICH guidelines. Our team is prepared ...

About the Company : Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure a...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
4-Chloro-7-Tosyl-7HPyrrolo[ 2,3-d]Pyrimidine
CAS Number : CAS-479633-63-1
End Use API : Oclacitinib Maleate
About The Company : Almelo are the industry leaders in manufacturing advanced intermediates, Active Pharmaceutical Ingredients (APIs) and specialty fine chemicals. With a diverse p...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 3.6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 3.6MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5.4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 5.4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 16MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 16MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name : Oclacitinib
Dosage Form : Chewable Tablet
Dosage Strength : 3.6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Chewable Tablet
Dosage Strength : 3.6MG
Brand Name : Oclacitinib
Approval Date :
Application Number :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name : Oclacitinib
Dosage Form : Chewable Tablet
Dosage Strength : 5.4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Chewable Tablet
Dosage Strength : 5.4MG
Brand Name : Oclacitinib
Approval Date :
Application Number :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name : Oclacitinib
Dosage Form : Chewable Tablet
Dosage Strength : 5.4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Chewable Tablet
Dosage Strength : 5.4MG
Brand Name : Oclacitinib
Approval Date :
Application Number :
Registration Country : China

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
76
PharmaCompass offers a list of Oclacitinib Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oclacitinib Maleate manufacturer or Oclacitinib Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oclacitinib Maleate manufacturer or Oclacitinib Maleate supplier.
PharmaCompass also assists you with knowing the Oclacitinib Maleate API Price utilized in the formulation of products. Oclacitinib Maleate API Price is not always fixed or binding as the Oclacitinib Maleate Price is obtained through a variety of data sources. The Oclacitinib Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oclacitinib Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oclacitinib Maleate, including repackagers and relabelers. The FDA regulates Oclacitinib Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oclacitinib Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oclacitinib Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oclacitinib Maleate supplier is an individual or a company that provides Oclacitinib Maleate active pharmaceutical ingredient (API) or Oclacitinib Maleate finished formulations upon request. The Oclacitinib Maleate suppliers may include Oclacitinib Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Oclacitinib Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oclacitinib Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oclacitinib Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oclacitinib Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oclacitinib Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oclacitinib Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oclacitinib Maleate suppliers with NDC on PharmaCompass.
Oclacitinib Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oclacitinib Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oclacitinib Maleate GMP manufacturer or Oclacitinib Maleate GMP API supplier for your needs.
A Oclacitinib Maleate CoA (Certificate of Analysis) is a formal document that attests to Oclacitinib Maleate's compliance with Oclacitinib Maleate specifications and serves as a tool for batch-level quality control.
Oclacitinib Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Oclacitinib Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oclacitinib Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Oclacitinib Maleate EP), Oclacitinib Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oclacitinib Maleate USP).